Propensity score–weighted analysis of chemotherapy after PD-1 inhibitors versus chemotherapy alone in patients with non–small cell lung cancer (WJOG10217L)

BACKGROUND: Studies have suggested that chemotherapy after immune checkpoint inhibitors may confer an improved response for non–small cell lung cancer (NSCLC). However, potential selection bias in such studies has not been addressed. We therefore applied propensity score analysis to investigate the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kato, Ryoji, Hayashi, Hidetoshi, Chiba, Yasutaka, Miyawaki, Eriko, Shimizu, Junichi, Ozaki, Tomohiro, Fujimoto, Daichi, Toyozawa, Ryo, Nakamura, Atsushi, Kozuki, Toshiyuki, Tanaka, Kentaro, Teraoka, Shunsuke, Usui, Kazuhiro, Nishino, Kazumi, Hataji, Osamu, Ota, Keiichi, Ebi, Noriyuki, Saeki, Sho, Akazawa, Yuki, Okuno, Motoyasu, Yamamoto, Nobuyuki, Nakagawa, Kazuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Clinical/Translational Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057433/
https://www.ncbi.nlm.nih.gov/pubmed/32066647
http://dx.doi.org/10.1136/jitc-2019-000350

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7057433/
https://www.ncbi.nlm.nih.gov/pubmed/32066647
http://dx.doi.org/10.1136/jitc-2019-000350

Ejemplares similares